Liarikos S, Rapidis A D, Roumeliotis A, Angelopoulos A P
Department of Ophthalmology, Greek Anticancer Institute, 171 Alexandras Avenue, Athens 115 22, Greece.
J Craniomaxillofac Surg. 2000 Jun;28(3):148-52. doi: 10.1054/jcms.2000.0132.
Orbital melanomas comprise a heterogeneous group of pigmented tumours originating from melanocytes of the ophthalmic tissues, or represent distant metastases of cutaneous melanomas to the orbit. They can be classified into primary and secondary orbital melanomas. Whereas primary orbital melanomas are extremely rare, secondary orbital melanomas are seen more often and usually represent massive extrascleral extensions of uveal melanomas. Their diagnosis is difficult and controversy exists both about the treatment policy and regarding the prognosis. In an effort to clarify some of the aspects of the biological behaviour of these intriguing lesions, we retrospectively reviewed all orbital melanomas treated in our departments during the last eight years. The records of 15 patients with massive secondary orbital melanomas treated surgically were reviewed and analysed. Eleven of the patients were female and four were male. The mean age at the time of surgery was 68 years. Presenting features included unilateral orbital mass, often with painless proptosis, conjuctival bleeding, acute glaucoma crisis, decreased visual acuity and intermittent diplopia. The site of origin was the uveal tract in nine cases, the conjunctiva in three, the eyelids in two and the skin of the lower extremity in one patient. All patients were treated surgically with various types of orbital exenteration. Additional treatment included radiotherapy and chemotherapy. Two patients died from intracranial extension of the disease and 10 died from distant metastases. Three patients are alive with no evidence of disease. The longest survival was 33 months and the mean survival was 16.6 months. Early diagnosis and proper management of ocular melanoma prevents orbital extension and prolongs patient survival. Surgical treatment of secondary orbital melanoma with or without adjuvant radiotherapy and/or chemotherapy does not seem to improve patient survival when compared with conservative treatment used in other reports. However, orbital exenteration is effective for local control of the disease.
眼眶黑色素瘤是一组异质性色素性肿瘤,起源于眼组织的黑素细胞,或者是皮肤黑色素瘤转移至眼眶的远处转移瘤。它们可分为原发性和继发性眼眶黑色素瘤。原发性眼眶黑色素瘤极为罕见,而继发性眼眶黑色素瘤较为常见,通常表现为葡萄膜黑色素瘤的大量巩膜外扩展。其诊断困难,在治疗策略和预后方面均存在争议。为了阐明这些有趣病变的生物学行为的某些方面,我们回顾性分析了过去八年在我们科室接受治疗的所有眼眶黑色素瘤病例。对15例接受手术治疗的大量继发性眼眶黑色素瘤患者的记录进行了回顾和分析。其中11例为女性,4例为男性。手术时的平均年龄为68岁。临床表现包括单侧眼眶肿块,常伴有无痛性眼球突出、结膜出血、急性青光眼发作、视力下降和间歇性复视。起源部位:9例为葡萄膜,3例为结膜,2例为眼睑,1例为下肢皮肤。所有患者均接受了不同类型的眼眶内容剜除术。辅助治疗包括放疗和化疗。2例患者死于疾病的颅内扩展,10例死于远处转移。3例患者存活且无疾病证据。最长生存期为33个月,平均生存期为16.6个月。眼部黑色素瘤的早期诊断和恰当处理可预防眼眶扩展并延长患者生存期。与其他报道中使用的保守治疗相比,继发性眼眶黑色素瘤的手术治疗联合或不联合辅助放疗和/或化疗似乎并未改善患者生存期。然而,眼眶内容剜除术对疾病的局部控制有效。